Jean-pierre M. Brion

808 Route De Lennik
Brussels, BRU 1070, Belgium

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 69 publications

PICALM Genetic Variant Alters mRNA Expression Without Affecting Protein Levels or Tau Spreading in Alzheimer's Disease.

PICALM Genetic Variant Alters mRNA Expression Without Affecting Protein Levels or Tau Spreading in Alzheimer's Disease.

Journal: Cells
Published: November 21, 2025

The Determinant of Tau Spreading in Alzheimer's Disease: Dependent on Senile Plaque, Neural Circuits, or Spatial Proximity?

The Determinant of Tau Spreading in Alzheimer's Disease: Dependent on Senile Plaque, Neural Circuits, or Spatial Proximity?

Journal: International journal of molecular sciences
Published: November 15, 2025

Differential effects of age and sex on tau pathology propagation in the htau mouse model: A neuropathological and proteomic study.

Differential effects of age and sex on tau pathology propagation in the htau mouse model: A neuropathological and proteomic study.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: July 16, 2025

Dysregulation of Inositol Polyphosphate 5-Phosphatase OCRL in Alzheimer's Disease: Implications for Autophagy Dysfunction.

Dysregulation of Inositol Polyphosphate 5-Phosphatase OCRL in Alzheimer's Disease: Implications for Autophagy Dysfunction.

Journal: International journal of molecular sciences
Published: May 07, 2025

Differentially expressed miRNAs in the temporal cortex of Alzheimer's disease patients and their association to tau pathology.

Differentially expressed miRNAs in the temporal cortex of Alzheimer's disease patients and their association to tau pathology.

Journal: Communications biology
Published: April 15, 2025

Deletion of Murine APP Aggravates Tau and Amyloid Pathologies in the 5xFADXTg30 Alzheimer's Disease Model.

Deletion of Murine APP Aggravates Tau and Amyloid Pathologies in the 5xFADXTg30 Alzheimer's Disease Model.

Journal: Biomolecules
Published: December 07, 2024

Downregulation of hsa-miR-132 and hsa-miR-129: non-coding RNA molecular signatures of Alzheimer's disease.

Downregulation of hsa-miR-132 and hsa-miR-129: non-coding RNA molecular signatures of Alzheimer's disease.

Journal: Frontiers in molecular neuroscience
Published: April 25, 2024

Alteration of gene expression and protein solubility of the PI 5-phosphatase SHIP2 are correlated with Alzheimer's disease pathology progression.

Alteration of gene expression and protein solubility of the PI 5-phosphatase SHIP2 are correlated with Alzheimer's disease pathology progression.

Journal: Acta neuropathologica
Published: April 15, 2024

Shaping the future of preclinical development of successful disease-modifying drugs against Alzheimer's disease: a systematic review of tau propagation models.

Shaping the future of preclinical development of successful disease-modifying drugs against Alzheimer's disease: a systematic review of tau propagation models.

Journal: Acta neuropathologica communications
Published: January 11, 2024

Loss of Ephaptic Contacts in the Murine Thalamus during Osmotic Demyelination Syndrome.

Loss of Ephaptic Contacts in the Murine Thalamus during Osmotic Demyelination Syndrome.

Journal: Ultrastructural pathology
Published: July 21, 2023

PICALM and Alzheimer's Disease: An Update and Perspectives.

PICALM and Alzheimer's Disease: An Update and Perspectives.

Journal: Cells
Published: August 10, 2022

A primary cilium in oligodendrocytes: a fine structure signal of repairs in thalamic Osmotic Demyelination Syndrome (ODS).

A primary cilium in oligodendrocytes: a fine structure signal of repairs in thalamic Osmotic Demyelination Syndrome (ODS).

Journal: Ultrastructural pathology
Published: June 22, 2021
Showing 1-12 of 69

Last Updated: 09/26/2026